Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Altimmune (ALT) Preferred Shares Issued (2016 - 2017)

Altimmune (ALT) has disclosed Preferred Shares Issued for 2 consecutive years, with $13.0 million as the latest value for Q3 2017.

  • Quarterly Preferred Shares Issued rose 548.63% to $13.0 million in Q3 2017 from the year-ago period, while the trailing twelve-month figure was $15.0 million through Dec 2017, changed N/A year-over-year, with the annual reading at $13.0 million for FY2017, 129.46% up from the prior year.
  • Preferred Shares Issued for Q3 2017 was $13.0 million at Altimmune, up from $2.0 million in the prior quarter.
  • The five-year high for Preferred Shares Issued was $13.0 million in Q3 2017, with the low at $2.0 million in Q3 2016.